abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

27 Dec 2010

Author:
ABC [Austrailia]

Drug trials undertaken in India and the reporting of medical trials

Australians don't realise that many of the medications they'll be consuming in the future will have been trialled in India. The reasons drug companies are going there are that it's cheap and ethical controls are weak or non-existent. Indian researchers are sounding warnings. Also, an eminent statistician talks about problems in reporting of medical trials... [Transcript of interview with Dr Amar Jesani, founder of the Centre for Studies in Ethics and Rights in Mumbai; Raju Chacko, medical oncologist in Vellore, Southern India; Prof. Doug Altman, director of the University of Oxford's Centre for Statistics in Medicine]... A. Jesani: "...There's no regulation because there are no minimum standards set...The pharmaceutical companies are finding it difficult to recruit participants in their own countries because people like to go through treatment which is standard treatment,...they don't want to get experimented on..."